Related Experiment Videos
Prenatal diagnosis of glucose-6-phosphate-dehydrogenase deficiency
1Department of Molecular and Experimental Medicine Scripps Clinic and Research Foundation, La Jolla, CA 92037.
Insights
Prenatal diagnosis of G6PD deficiency is now possible using DNA technology. This allows for the determination of fetal inheritance of the normal glucose-6-phosphate dehydrogenase gene.
Area of Science:
- Genetics
- Molecular Biology
- Prenatal Diagnostics
Background:
- Glucose-6-phosphate dehydrogenase (G6PD) deficiency diagnosis was previously unreliable before DNA technology.
- Genetic disorders require accurate prenatal diagnostic methods.
Purpose of the Study:
- To establish a reliable prenatal diagnostic method for G6PD deficiency.
- To demonstrate the feasibility of DNA-based prenatal testing for G6PD deficiency.
Main Methods:
- Polymerase Chain Reaction (PCR) amplification of the G6PD gene.
- Restriction endonuclease digestion for analysis.
- Analysis of fetal DNA from a heterozygous mother.
Main Results:
- Successful prenatal diagnosis of G6PD deficiency is achievable.
- The male fetus inherited the normal G6PD gene from the heterozygous mother.
- Demonstrated the utility of PCR and restriction digestion for G6PD gene analysis.
Conclusions:
- DNA-based technology, specifically PCR and restriction digestion, enables reliable prenatal diagnosis of G6PD deficiency.
- This method can identify fetal inheritance of specific G6PD gene variants.
- Accurate prenatal diagnosis of G6PD deficiency is now clinically feasible.
Abstract:
Prior to the development of the DNA-based technology reliable prenatal diagnosis of G6PD deficiency was not possible. We show that, using PCR amplification and restriction endonuclease digestion, prenatal diagnosis is possible. We have now been able to determine that the male fetus of a mother heterozygous for G6PD Mediterranean had inherited the maternal X chromosome with the normal G6PD gene.